Sign in

CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company

BIOMERICA INC

Sign in to watch
Ticker
BMRA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
May 31
Incorporated
DE
Entity type
operating
EIN
952645573
Phone
9493792875
Business address
17571 VON KARMAN AVENUE, IRVINE, CA, 92614
  1. 4 Option exercise Director acquired 25,000 shares (option exercise)
  2. 4 Open-market sale Chief Financial Officer sold 4,500 shares at $2.20 ($9,888)
  3. 4 Option exercise Chief Financial Officer acquired 3,000 shares (option exercise)
  4. 4/A Open-market sale Chief Financial Officer sold 9,780 shares at an average $2.18 ($21,337)
  5. 4 Open-market sale Chief Financial Officer sold 9,780 shares at an average $2.18 ($21,337)
  6. 4 Open-market sale President sold 9,351 shares at $2.77 ($25,873)
  7. 4 Open-market sale President sold 10,649 shares at an average $2.89 ($30,780)
  8. 4/A Option exercise Chief Executive Officer acquired 75,000 shares (option exercise)
  9. 4 Option exercise Chief Executive Officer acquired 75,000 shares (option exercise)
  10. 4 Option exercise Director acquired 25,000 shares (option exercise)
  11. 4 Open-market buy Chief Executive Officer bought 400 shares at an average $1.94 ($777)
  12. 4 Open-market buy Chief Executive Officer bought 500 shares at an average $1.74 ($870)
  13. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $1.95 ($1,950)
  14. 4 Open-market sale President sold 10,000 shares at $2.68 ($26,841)
  15. 10-Q Report Quarterly Report
  16. 4 Open-market buy Director bought 1,000 shares at $2.80 ($2,804)
  17. DEF 14A Proxy Proxy Statement
  18. 8-K Event Other events
  19. 4 Open-market buy Chief Executive Officer bought 199 shares at $2.65 ($527)
  20. 10-K Report Annual Report

Page 15 of 31 · 605 filings